<VariationArchive VariationID="1049809" VariationName="NM_000535.7(PMS2):c.2506del (p.Glu836fs)" VariationType="Deletion" Accession="VCV001049809" Version="6" RecordType="classified" NumberOfSubmissions="5" NumberOfSubmitters="5" DateLastUpdated="2024-06-17" DateCreated="2021-04-13" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1037794" VariationID="1049809">
      <GeneList>
        <Gene Symbol="PMS2" FullName="PMS1 homolog 2, mismatch repair system component" GeneID="5395" HGNC_ID="HGNC:9122" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="5970925" stop="6009106" display_start="5970925" display_stop="6009106" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="6012869" stop="6048736" display_start="6012869" display_stop="6048736" Strand="-" />
          </Location>
          <OMIM>600259</OMIM>
          <Haploinsufficiency last_evaluated="2015-11-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PMS2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2015-11-15" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=PMS2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000535.7(PMS2):c.2506del (p.Glu836fs)</Name>
      <CanonicalSPDI>NC_000007.14:5973481:CCCCC:CCCC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="5973482" stop="5973482" display_start="5973482" display_stop="5973482" variantLength="1" positionVCF="5973481" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="6013113" stop="6013113" display_start="6013113" display_stop="6013113" variantLength="1" referenceAllele="TC" alternateAllele="T" positionVCF="6013112" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E525fs</ProteinChange>
      <ProteinChange>E645fs</ProteinChange>
      <ProteinChange>E649fs</ProteinChange>
      <ProteinChange>E701fs</ProteinChange>
      <ProteinChange>E712fs</ProteinChange>
      <ProteinChange>E730fs</ProteinChange>
      <ProteinChange>E733fs</ProteinChange>
      <ProteinChange>E784fs</ProteinChange>
      <ProteinChange>E836fs</ProteinChange>
      <ProteinChange>E847fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.6013117del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.6013117del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.5973486del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.5973486del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008466.1" sequenceAccession="NG_008466" sequenceVersion="1" change="g.40625del">
            <Expression>NG_008466.1:g.40625del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000535.7" sequenceAccession="NM_000535" sequenceVersion="7" change="c.2506del" MANESelect="true">
            <Expression>NM_000535.7:c.2506del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000526.2" sequenceAccession="NP_000526" sequenceVersion="2" change="p.Glu836fs">
            <Expression>NP_000526.2:p.Glu836fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322003.2" sequenceAccession="NM_001322003" sequenceVersion="2" change="c.2101del">
            <Expression>NM_001322003.2:c.2101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308932.1" sequenceAccession="NP_001308932" sequenceVersion="1" change="p.Glu701fs">
            <Expression>NP_001308932.1:p.Glu701fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322004.2" sequenceAccession="NM_001322004" sequenceVersion="2" change="c.2101del">
            <Expression>NM_001322004.2:c.2101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308933.1" sequenceAccession="NP_001308933" sequenceVersion="1" change="p.Glu701fs">
            <Expression>NP_001308933.1:p.Glu701fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322005.2" sequenceAccession="NM_001322005" sequenceVersion="2" change="c.2101del">
            <Expression>NM_001322005.2:c.2101del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308934.1" sequenceAccession="NP_001308934" sequenceVersion="1" change="p.Glu701fs">
            <Expression>NP_001308934.1:p.Glu701fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322006.2" sequenceAccession="NM_001322006" sequenceVersion="2" change="c.2350del">
            <Expression>NM_001322006.2:c.2350del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308935.1" sequenceAccession="NP_001308935" sequenceVersion="1" change="p.Glu784fs">
            <Expression>NP_001308935.1:p.Glu784fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322007.2" sequenceAccession="NM_001322007" sequenceVersion="2" change="c.2188del">
            <Expression>NM_001322007.2:c.2188del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308936.1" sequenceAccession="NP_001308936" sequenceVersion="1" change="p.Glu730fs">
            <Expression>NP_001308936.1:p.Glu730fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322008.2" sequenceAccession="NM_001322008" sequenceVersion="2" change="c.2188del">
            <Expression>NM_001322008.2:c.2188del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308937.1" sequenceAccession="NP_001308937" sequenceVersion="1" change="p.Glu730fs">
            <Expression>NP_001308937.1:p.Glu730fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322009.2" sequenceAccession="NM_001322009" sequenceVersion="2" change="c.2134del">
            <Expression>NM_001322009.2:c.2134del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308938.1" sequenceAccession="NP_001308938" sequenceVersion="1" change="p.Glu712fs">
            <Expression>NP_001308938.1:p.Glu712fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322010.2" sequenceAccession="NM_001322010" sequenceVersion="2" change="c.1945del">
            <Expression>NM_001322010.2:c.1945del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308939.1" sequenceAccession="NP_001308939" sequenceVersion="1" change="p.Glu649fs">
            <Expression>NP_001308939.1:p.Glu649fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322011.2" sequenceAccession="NM_001322011" sequenceVersion="2" change="c.1573del">
            <Expression>NM_001322011.2:c.1573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308940.1" sequenceAccession="NP_001308940" sequenceVersion="1" change="p.Glu525fs">
            <Expression>NP_001308940.1:p.Glu525fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322012.2" sequenceAccession="NM_001322012" sequenceVersion="2" change="c.1573del">
            <Expression>NM_001322012.2:c.1573del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308941.1" sequenceAccession="NP_001308941" sequenceVersion="1" change="p.Glu525fs">
            <Expression>NP_001308941.1:p.Glu525fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322013.2" sequenceAccession="NM_001322013" sequenceVersion="2" change="c.1933del">
            <Expression>NM_001322013.2:c.1933del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308942.1" sequenceAccession="NP_001308942" sequenceVersion="1" change="p.Glu645fs">
            <Expression>NP_001308942.1:p.Glu645fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322014.2" sequenceAccession="NM_001322014" sequenceVersion="2" change="c.2539del">
            <Expression>NM_001322014.2:c.2539del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308943.1" sequenceAccession="NP_001308943" sequenceVersion="1" change="p.Glu847fs">
            <Expression>NP_001308943.1:p.Glu847fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001322015.2" sequenceAccession="NM_001322015" sequenceVersion="2" change="c.2197del">
            <Expression>NM_001322015.2:c.2197del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001308944.1" sequenceAccession="NP_001308944" sequenceVersion="1" change="p.Glu733fs">
            <Expression>NP_001308944.1:p.Glu733fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_136154.1" sequenceAccession="NR_136154" sequenceVersion="1" change="n.2550del">
            <Expression>NR_136154.1:n.2550del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_161" sequenceAccession="LRG_161">
            <Expression>LRG_161:g.40625del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_161t1" sequenceAccession="LRG_161t1">
            <Expression>LRG_161t1:c.2506del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2128658092" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000535.7(PMS2):c.2506del (p.Glu836fs) AND Carcinoma of colon" Accession="RCV001356384" Version="1">
        <ClassifiedConditionList TraitSetID="1735">
          <ClassifiedCondition DB="MedGen" ID="C0699790">Carcinoma of colon</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2506del (p.Glu836fs) AND Hereditary cancer-predisposing syndrome" Accession="RCV002456535" Version="2">
        <ClassifiedConditionList TraitSetID="13598">
          <ClassifiedCondition DB="MedGen" ID="C0027672">Hereditary cancer-predisposing syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-02-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2506del (p.Glu836fs) AND Lynch syndrome 4" Accession="RCV003450000" Version="2">
        <ClassifiedConditionList TraitSetID="2540">
          <ClassifiedCondition DB="MedGen" ID="C1838333">Lynch syndrome 4</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-29" SubmissionCount="2">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000535.7(PMS2):c.2506del (p.Glu836fs) AND Hereditary nonpolyposis colorectal neoplasms" Accession="RCV003771042" Version="1">
        <ClassifiedConditionList TraitSetID="37727">
          <ClassifiedCondition DB="MedGen" ID="C0009405">Hereditary nonpolyposis colorectal neoplasms</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-06" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-06" NumberOfSubmissions="5" NumberOfSubmitters="5" DateCreated="2021-04-13" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10037723</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16338176</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20533529</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26116798</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30764633</ID>
        </Citation>
        <DescriptionHistory Dated="2023-12-23">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="13598" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="18746" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hereditary neoplastic syndrome</ElementValue>
                <XRef ID="MONDO:0015356" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tumor predisposition</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cancer predisposition</ElementValue>
                <XRef ID="Hereditary+Cancer/3345" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary Cancer Syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neoplastic Syndromes, Hereditary</ElementValue>
                <XRef ID="D009386" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hereditary cancer-predisposing syndrome</ElementValue>
                <XRef ID="699346009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="19921" />
                <XRef ID="19921" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <Citation Type="general" Abbrev="IARC, 2008">
                <ID Source="pmc">3075918</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/NSGC, 2015">
                <ID Source="PubMed">25394175</ID>
              </Citation>
              <XRef ID="140162" DB="Orphanet" />
              <XRef ID="C0027672" DB="MedGen" />
              <XRef ID="D009386" DB="MeSH" />
              <XRef ID="MONDO:0015356" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1735" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="10229" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Colonic carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carcinoma of colon</ElementValue>
                <XRef ID="269533000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colon carcinoma</ElementValue>
                <XRef ID="MONDO:0002032" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CRC</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Lynch syndrome is characterized by an increased risk for colorectal cancer (CRC) and cancers of the endometrium, ovary, stomach, small bowel, urinary tract, biliary tract, brain (usually glioblastoma), skin (sebaceous adenomas, sebaceous carcinomas, and keratoacanthomas), pancreas, and prostate. Cancer risks and age of onset vary depending on the associated gene. Several other cancer types have been reported to occur in individuals with Lynch syndrome (e.g., breast, sarcomas, adrenocortical carcinoma). However, the data are not sufficient to demonstrate that the risk of developing these cancers is increased in individuals with Lynch syndrome.</Attribute>
                <XRef ID="NBK1211" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301390</ID>
                <ID Source="BookShelf">NBK1211</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743612</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2009">
                <ID Source="pmc">2743610</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="AMA/NCHPEG, 2012">
                <URL>http://www.nchpeg.org/documents/crc/11-0456%20Fact%20sheets%20(MSI%20and%20IHC%20testing).pdf</URL>
              </Citation>
              <Citation Type="general" Abbrev="NACB, 2008">
                <ID Source="PubMed">19042984</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="AHRQ, 2013">
                <URL>https://www.cms.gov/Medicare/Coverage/DeterminationProcess/downloads/id90TA.pdf</URL>
                <CitationText>Technology Assessment on Genetic Testing or Molecular Pathology Testing of Cancers with Unknown Primary Site to Determine Origin (ARCHIVED)</CitationText>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Imperiale et al., 2014">
                <ID Source="PubMed">25006736</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2006">
                <ID Source="PubMed">17060676</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="NCCN, 2011">
                <ID Source="PubMed">22138009</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACP MPDG, 2014">
                <ID Source="PubMed">24996433</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2012">
                <ID Source="PubMed">22855150</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESMO, 2012">
                <ID Source="PubMed">23012255</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2015">
                <ID Source="PubMed">25373533</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGTM, 2014">
                <ID Source="PubMed">23852704</ID>
              </Citation>
              <Citation Type="general" Abbrev="EGAPP, 2013">
                <ID Source="PubMed">23429431</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Colon Cancer, 2024</CitationText>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="general" Abbrev="SEAP/SEOM, 2020">
                <ID Source="PubMed">32418154</ID>
                <ID Source="pmc">7505870</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2012">
                <URL>https://www.acmg.net/PDFLibrary/Colon-Cancer.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics Family History ACT Sheet, Colon Cancer (Asymptomatic), 2012</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <XRef ID="C0699790" DB="MedGen" />
              <XRef ID="MONDO:0002032" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="2540" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="10524" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Lynch syndrome 4</ElementValue>
                <XRef ID="MONDO:0013699" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Colorectal cancer, hereditary nonpolyposis, type 4</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary non-polyposis colorectal cancer, type 4</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LYNCH4</ElementValue>
                <XRef Type="MIM" ID="614337" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15791" />
                <XRef ID="15791" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000530120" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000501424" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512645" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000514731" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528529" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000510418" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512402" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000512403" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000528914" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="EHTG/ESCP, 2021">
                <ID Source="PubMed">34043773</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2019">
                <URL>https://www.acmg.net/PDFLibrary/Lynch-Syndrome.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Genomic Testing (Secondary Findings) ACT Sheet, MLH1, MSH2, MSH6, PMS2, EPCAM Pathogenic Variants, Lynch Syndrome (Hereditary Non-polyposis Colon Cancer [HNPCC]), 2019</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2021">
                <URL>https://www.nice.org.uk/guidance/ng151</URL>
                <CitationText>UK NICE Guideline NG151, Colorectal cancer, 2021</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NICE, 2020">
                <URL>https://www.nice.org.uk/guidance/dg42</URL>
                <CitationText>UK NICE Diagnostics Guidance DG42, Testing strategies for Lynch syndrome in people with endometrial cancer, 2020</CitationText>
              </Citation>
              <XRef ID="144" DB="Orphanet" />
              <XRef ID="C1838333" DB="MedGen" />
              <XRef ID="MONDO:0013699" DB="MONDO" />
              <XRef Type="MIM" ID="614337" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="37727" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="38245" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary nonpolyposis colorectal neoplasms</ElementValue>
                <XRef ID="D003123" DB="MeSH" />
              </Name>
              <XRef ID="C0009405" DB="MedGen" />
              <XRef ID="D003123" DB="MeSH" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3052477" SubmissionDate="2021-03-31" DateLastUpdated="2021-04-13" DateCreated="2021-04-13">
        <ClinVarSubmissionID localKey="chr7:6013111-6013113:1e8b763a44076fb61edb1f0115e0844f-COLON" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001551536" DateUpdated="2021-04-13" DateCreated="2021-04-13" Type="SCV" Version="1" SubmitterName="Department of Pathology and Laboratory Medicine, Sinai Health System" OrgID="506152" OrganizationCategory="laboratory" OrgAbbreviation="PLM-SHS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506759" SubmitterName="Franklin by Genoox" Type="secondary" OrganizationCategory="other" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The PMS2 p.Glu836Argfs*15 variant was not identified in the literature nor was it identified in the dbSNP or ClinVar. However, a variant resulting in a nearby frameshift (PMS2:c.2500_2501delinsG, p.Met834Glyfs*17) has been reported in ClinVar and was classified as pathogenic by Invitae, Ambry Genetics and one other submitter and as likely pathogenic by one submitter. The p.Glu836Argfs*15 variant was not identified in the Exome Aggregation Consortium (August 8th 2016), or the Genome Aggregation Database (Feb 27, 2017). The c.2506del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 836 and leads to a premature stop codon 15 codons downstream. The variant may not result in nonsense mediated decay as this variant is near the 3' end of the gene. The predicted removal of the last 27 amino acids of the protein may affect protein function because this region has been shown to be important for binding to MLH1, which is required for mismatch-repair activity and residues in this region have also been shown to be involved in endonuclease activity and zinc binding (Gurrette 1999, Kosinski 2008). This variant was also identified by our laboratory in a patient with a PMS2-deficient colon tumour, increasing the likelihood that this variant has clinical significance. In summary, based on the above information, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="7" alternateAllele="T" referenceAllele="TC" start="6013112" stop="6013113" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0002032" />
          </Trait>
        </TraitSet>
        <StudyName>The Canadian Open Genetics Repository (COGR)</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB9371647</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7828404" SubmissionDate="2023-12-21" DateLastUpdated="2023-12-24" DateCreated="2023-12-24">
        <ClinVarSubmissionID localKey="100003003|OMIM:614337" />
        <ClinVarAccession Accession="SCV004187564" DateUpdated="2023-12-24" DateCreated="2023-12-24" Type="SCV" Version="1" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-09-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>This variant is considered likely pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/8ufcwsf2/myriad_genetics_classification_criteria_2023.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="hg19" Chr="7" alternateAllele="T" referenceAllele="TC" start="6013112" stop="6013113" />
          </Location>
          <OtherNameList>
            <Name Type="SubmitterVariantId">100003003</Name>
          </OtherNameList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14104645</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8597876" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="13091953|MedGen:C0009405" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004640937" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-06">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10037723</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16338176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20533529</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16338176</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20533529</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26116798</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30764633</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Glu836Argfs*15) in the PMS2 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 27 amino acid(s) of the PMS2 protein. The frequency data for this variant in the population databases (gnomAD) is considered unreliable due to the presence of homologous sequence, such as pseudogenes or paralogs, in the genome. This variant has not been reported in the literature in individuals affected with PMS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1049809). This variant disrupts the MLH1 interaction domain of the PMS2 protein, which has been shown to be critical for PMS2-MLH1 dimerization (PMID: 10037723), and therefore mismatch repair activity (PMID: 16338176, 20533529). While functional studies have not been performed to directly test the effect of this variant on PMS2 protein function, this suggests that disruption of this region of the protein is causative of disease. This variant disrupts a region of the PMS2 protein in which other variant(s) (p.Trp841Glyfs*10) have been determined to be pathogenic (PMID: 16338176, 20533529, 26116798, 30764633; Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.6013113del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0009405" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5224807" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2022-11-29">
        <ClinVarSubmissionID localKey="a621459|MedGen:C0027672" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002738833" DateUpdated="2024-05-01" DateCreated="2022-11-29" Type="SCV" Version="2" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The c.2506delG pathogenic mutation, located in coding exon 15 of the PMS2 gene, results from a deletion of one nucleotide at nucleotide position 2506, causing a translational frameshift with a predicted alternate stop codon (p.E836Rfs*15). This alteration is expected to result in loss of function by premature protein truncation. As such, this alteration is interpreted as a disease-causing mutation.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PMS2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.5:c.2506delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0027672" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="9813226" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2024-06-17">
        <ClinVarSubmissionID localKey="NM_000535.7:c.2506del|OMIM:614337" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV005056499" DateUpdated="2024-06-17" DateCreated="2024-06-17" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-29">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000535.7:c.2506del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="614337" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7828404" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3052477" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0002032" MappingRef="MONDO">
        <MedGen CUI="C0699790" Name="Carcinoma of colon" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="9813226" TraitType="Disease" MappingType="XRef" MappingValue="614337" MappingRef="OMIM">
        <MedGen CUI="C1838333" Name="Lynch syndrome 4" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5224807" TraitType="Disease" MappingType="XRef" MappingValue="C0027672" MappingRef="MedGen">
        <MedGen CUI="C0027672" Name="Hereditary cancer-predisposing syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8597876" TraitType="Disease" MappingType="XRef" MappingValue="C0009405" MappingRef="MedGen">
        <MedGen CUI="C0009405" Name="Hereditary nonpolyposis colorectal neoplasms" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

